Research shows: Slowed progression of chronic kidney disease (CKD) Reduced proteinuria (albumin in urine) , an early marker of kidney damage Improved kidney filtration rates over time The FLOW trial with semaglutide demonstrated that GLP-1 therapy could significantly reduce the risk of kidney failure in patients with type 2 diabetes and CKD
Rainey RP, Gillman IG, Shi X, Cheng T, Stinson A, Gietl D, Albino AP: Fluorescent detection of lipid peroxidation derived protein adducts upon in-vitro cigarette smoke exposure
Mutations of the BRAF gene in benign and malignant melanocytic lesions
Extra caution is advised for individuals with very sensitive skin or darker skin tones (Types V and VI)
This approach promotes sustained weight loss and improves metabolic health
Learn more about our other compounded sexual wellness therapies